|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/495 | |
| A61P 3/10 |
| (11) | Patento numeris | 1505977 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03755446.6 |
| Europos patento paraiškos padavimo data | 2003-05-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-02-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-09-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/016277 |
| Data | 2003-05-21 |
| (87) | Numeris | WO 2003/099281 |
| Data | 2003-12-04 |
| (30) | Numeris | Data | Šalis |
| 382781 P | 2002-05-21 | US | |
| 459332 P | 2003-03-31 | US |
| (72) |
WOLFF, Andrew, US
JERLING, Markus, SE
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ADMINISTRATION OF A PARTIAL FATTY ACID OXIDATION INHIBITOR SUCH AS RANOLAZINE FOR THE TREATMENT OF DIABETES |
| ADMINISTRATION OF A PARTIAL FATTY ACID OXIDATION INHIBITOR SUCH AS RANOLAZINE FOR THE TREATMENT OF DIABETES |